Related references
Note: Only part of the references are listed.Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway
Shi-Bo Bian et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2021)
TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues
Aron Bartha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The emerging role of leukemia inhibitory factor in cancer and therapy
Cen Zhang et al.
PHARMACOLOGY & THERAPEUTICS (2021)
Endometrial Axin2+ Cells Drive Epithelial Homeostasis, Regeneration, and Cancer following Oncogenic Transformation
Shafiq M. Syed et al.
CELL STEM CELL (2020)
Leukaemia Inhibitory Factor (LIF) Inhibits Cancer Stem Cells Tumorigenic Properties through Hippo Kinases Activation in Gastric Cancer
Lornella Seeneevassen et al.
CANCERS (2020)
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Adriana C. Rodriguez et al.
HORMONES & CANCER (2019)
EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer
Suryavathi Viswanadhapalli et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring
Yu Shi et al.
NATURE (2019)
Targeting Endometrial Cancer Stem Cell Activity with Metformin Is Inhibited by Patient-Derived Adipocyte-Secreted Factors
Sarah J. Kitson et al.
CANCERS (2019)
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer
Man-Tzu Wang et al.
NATURE COMMUNICATIONS (2019)
Endometrial Cancer Spheres Show Cancer Stem Cells Phenotype and Preference for Oxidative Metabolism
Maria Joao Carvalho et al.
PATHOLOGY & ONCOLOGY RESEARCH (2019)
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
Suryavathi Viswanadhapalli et al.
BREAST CANCER RESEARCH (2019)
Clinical actionability of molecular targets in endometrial cancer
Mary Ellen Urick et al.
NATURE REVIEWS CANCER (2019)
RNA Sequencing of Carboplatin- and Paclitaxel-Resistant Endometrial Cancer Cells Reveals New Stratification Markers and Molecular Targets for Cancer Treatment
Raffaele Hellweg et al.
HORMONES & CANCER (2018)
Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer
Tara E. Soumerai et al.
CLINICAL CANCER RESEARCH (2018)
Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
Ganesh V. Raj et al.
ELIFE (2017)
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment
Michaela A. Onstad et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Aromatase: Contributions to Physiology and Disease in Women and Men
Jennifer Blakemore et al.
PHYSIOLOGY (2016)
Leukemia inhibitory factor (LIF)
Nicos A. Nicola et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation
Stuart Duncan Morton et al.
ONCOTARGET (2015)
Dysregulated LIF-STAT3 pathway is responsible for impaired embryo implantation in a Streptozotocin-induced diabetic mouse model
Tong-Song Wang et al.
BIOLOGY OPEN (2015)
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
Xiaoyan Li et al.
ONCOTARGET (2014)
LIF Mediates Proinvasive Activation of Stromal Fibroblasts in Cancer
Jean Albrengues et al.
CELL REPORTS (2014)
Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma
Silke Kuphal et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
Shu-Chen Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Type I and II Endometrial Cancers: Have They Different Risk Factors?
Veronica Wendy Setiawan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Therapeutic Significance of Estrogen Receptor β Agonists in Gliomas
Gangadhara R. Sareddy et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Epigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer
Jung Eun Shin et al.
MOLECULES AND CELLS (2011)
TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
Silvia Penuelas et al.
CANCER CELL (2009)
Adjuvant Hormonal Therapy for Stage I Endometrial Cancer
Thomas K Oliver et al.
Current Oncology (2008)
Stat3 activation in human endometrial and cervical cancers
C-L Chen et al.
BRITISH JOURNAL OF CANCER (2007)
LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism
P Cartwright et al.
DEVELOPMENT (2005)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Leptin-induced increase in leukemia inhibitory factor and its receptor by human endometrium is partially mediated by interleukin 1 receptor signaling
RR Gonzalez et al.
ENDOCRINOLOGY (2004)
Share Paper
